Af de patienter, som oplevede myopati i forbindelse med cerivastatin, fik 61% ≤ 0, 4 mg, hvor 1% var titreret fra en lav til en høj dosis, og 37% skiftede fra et andet statin til en lav dosis cerivastatin.
Of those patients who experienced myopathy on cerivastatin, 61% were on ≤ 0.4mg, with 1% having been titrated from a low to a high dose and 37% switched from another statin to low dose cerivastatin.